{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:59:42Z","timestamp":1788303582341,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky295","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T03:10:11Z","timestamp":1530673811000},"page":"3170-3175","source":"Crossref","is-referenced-by-count":134,"title":["Effectiveness of ceftazidime\/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae"],"prefix":"10.1093","volume":"73","author":[{"given":"Adrian","family":"Sousa","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Galicia Sur (IIS Galicia Sur), Hospital \u00c1lvaro Cunqueiro Bloque t\u00e9cnico, Estrada Clara Campoamor 341, Vigo (Pontevedra), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"P\u00e9rez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Galicia Sur (IIS Galicia Sur), Hospital \u00c1lvaro Cunqueiro Bloque t\u00e9cnico, Estrada Clara Campoamor 341, Vigo (Pontevedra), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Soto","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez-Landeiro","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mart\u00ednez-Lamas","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Nodar","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Galicia Sur (IIS Galicia Sur), Hospital \u00c1lvaro Cunqueiro Bloque t\u00e9cnico, Estrada Clara Campoamor 341, Vigo (Pontevedra), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Crespo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit-Internal Medicine Department, Hospital \u00c1lvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Galicia Sur (IIS Galicia Sur), Hospital \u00c1lvaro Cunqueiro Bloque t\u00e9cnico, Estrada Clara Campoamor 341, Vigo (Pontevedra), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"key\n\t\t\t\t20181023055844598_dky295-B1","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B2","doi-asserted-by":"crossref","first-page":"1170e5.","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"73","author":"Zhanel","year":"2013","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B5","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/AAC.00163-15","article-title":"Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of \u03b2-lactamase producing strains","volume":"59","author":"Castanheira","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diagmicrobio.2015.06.008","article-title":"Ceftazidime-avibactam activity when tested against ceftazidime non-susceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from United States medical centers (2011-2014)","volume":"83","author":"Sader","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cid\/ciw378","article-title":"Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program","volume":"63","author":"Wagenlehner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/cid\/ciw133","article-title":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program","volume":"62","author":"Mazuski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomized, double-blind, phase 3 non-inferiority trial","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01964-16","article-title":"Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program","volume":"61","author":"Temkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B13","article-title":"Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae infections","volume":"5","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.mayocp.2016.06.024","article-title":"A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae","volume":"91","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B18","volume-title":"Prescribing Information","year":"2016"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B19","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth Edition M100-S28","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B21","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/AAC.00678-15","article-title":"In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase","volume":"59","author":"Livermore","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B22","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/AAC.04406-14","article-title":"Variants of \u03b2-lactamase KPC-2 that are resistant to inhibition by avibactam","volume":"59","author":"Papp-Wallace","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055844598_dky295-B23","first-page":"726","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume-title":"Lancet Infect Dis","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3170\/26144696\/dky295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T02:00:18Z","timestamp":1604541618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3170\/5067737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,8,7]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky295","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,8,7]]}}}